Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.
A Study of CTX340 in Participants with Uncontrolled Hypertension.
Age: ≥18 and ≤75 years. [+5]
Serum aldosterone and direct renin concentration (or plasma renin activity [PRA]... [+9]
This is a single-arm, open-label, multicenter, ascending dose Phase 1 trial that will enroll participants 18 to 75 years of age with dyslipidemias that are refractory to available treatments.
Age of ≥18 and ≤75 years at the time of signing the informed consent. [+5]
Participants with familial chylomicronemia syndrome (FCS). Some exceptions may a... [+6]
This is a single-arm, open-label, multicenter, ascending dose Phase 1/2 trial evaluating the safety and preliminary efficacy of CTX112 or Zugocabtagene geleucel (zugo-cel) in adult participants with relapsed/refractory primary Immune Thrombocytopenia (ITP) and relapsed/refractory primary Warm Autoimmune Hemolytic Anemia (wAIHA).
Age ≥18 years. [+5]
Prior treatment with anti-CD19 therapy or any gene therapy or genetically modifi... [+10]
This is an open-label, multicenter, Phase 1/2 study evaluating the safety and efficacy of CTX112™ in subjects with relapsed or refractory B-cell malignancies.
Age ≥18 years. [+4]
Prior allogeneic hematopoietic stem cell transplant (HSCT). [+8]